Cat.#: ASSD-131
| Description | Fluorescent metal ion indicator. Exhibits resistance to alkaline hydrolysis and displays similar calcium-binding properties to calcein. It fluoresces in both acidic and basic solutions when excited by the correct wavelength. Enhanced fluorescence is shown when bound to Ca (II), La (II) and Zn (II). Reduced fluorescence is shown when bound to Fe (II), Cu (II), Ni (II), Mn (II) and Co (II). |
| Size | 1 mg |
| Molecule Weight | 321.28 |
| Molecular formula | C15H15NO7 |
| CAS Number | 54375-47-2 |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-192 | 4-Fluoro-7-nitrobenzofurazan (AC192) | 5 mg, 25 mg, 50 mg | inquiry |
| ASSD-186 | Bromocresol Purple (AC186) | 5 g, 10 g | inquiry |
| ASSD-102 | DAPI (AC102) | 10 mg, 50 mg | inquiry |
| ASSD-179 | 8-Azidoadenosine-5′-diphosphate Sodium Salt (AC179) | 1 mg, 5 mg | inquiry |
| ASSD-166 | FURA-2 (AC166) | 1 mg | inquiry |
| ASSD-228 | ImmunoHistoMount (AC228) | 30 ml | inquiry |
| ASSD-214 | 8-Aminopyrene-1,3,6-trisulfonic acid trisodium salt (AC214) | 10 mg | inquiry |
| ASSD-122 | Fluorescent β2 antagonist [(±)-propranolol] (AC122) | 500 μg | inquiry |
| ASSD-140 | A2B covalent ligand (AC140) | 50 μg | inquiry |
| ASSD-101 | Cresyl Violet Solution (1%) (AC101) | 250 mL, 500 mL, | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.